Non-alcoholic fatty liver disease (NAFLD) is becoming more common in the general population around the world, especially in Asia. Sarcopenia is a condition characterized by a loss of muscle mass, strength, and function that occurs over time. Several studies have reported that sarcopenia is associated with nonalcoholic fatty liver disease in the general population. However, studies have investigated the association between sarcopenia and NAFLD in individuals with Type 2 diabetes mellitus (T2DM) i
Conditions
Interventions
The presence of low muscle mass and function were used to diagnose sarcopenia. TANITA BC-420 was used to obtain bioelectrical impedance (BIA). Skeletal muscle mass/height2 of less than 7 kg/m2 in male
Other,Other
Sponsors
Thai Association for the Study of the Liver (THASL)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age more than 18 years old with type 2 diabetes mellitus from the outpatient clinic at Siriraj hospital
Exclusion criteria
Exclusion criteria: Patients with viral hepatitis, alcoholic liver disease, metabolic liver disease, autoimmune liver disease, and hepatocellular carcinoma Patients with pregnancy Patients with significant alcohol consumption Patients with malignancy Patients with disability
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Presence of NAFLD at time of investigation CAP | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of NAFLD at time of investigation TE, FAST score | — |
Countries
Thailand
Contacts
Public ContactThitipon Chanjanakitskul
Siriraj hospital
Outcome results
None listed